These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9528374)

  • 21. Identifying and managing patients with hyperlipidemia.
    Clark AB; Holt JM
    Am J Manag Care; 1997 Aug; 3(8):1211-9; quiz 1223-5. PubMed ID: 10170303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I; Hamilton G; Humphrey A; Scragg A
    N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiovascular risk reduction: impact of an international project].
    Colle B; Brusaferro S;
    Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent assessment of cardiovascular heart disease risk factor attitudes and habits.
    Smalley SE; Wittler RR; Oliverson RH
    J Adolesc Health; 2004 Nov; 35(5):374-9. PubMed ID: 15488431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular risk factors. Different evaluations by physicians and patients].
    Bjerrum L; Hamm LR; Toft B; Munck AP; Kragstrup J
    Ugeskr Laeger; 2002 Nov; 164(46):5382-6. PubMed ID: 12469384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gaps in primary care documentation of cardiovascular risk factors.
    Rafter N; Wells S; Stewart A; Selak V; Whittaker R; Bramley D; Roseman P; Furness S; Jackson RT
    N Z Med J; 2008 Feb; 121(1269):24-33. PubMed ID: 18278079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locomotor disability in a cohort of British men: the impact of lifestyle and disease.
    Ebrahim S; Wannamethee SG; Whincup P; Walker M; Shaper AG
    Int J Epidemiol; 2000 Jun; 29(3):478-86. PubMed ID: 10869320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cultural factors and patients' adherence to lifestyle measures.
    Serour M; Alqhenaei H; Al-Saqabi S; Mustafa AR; Ben-Nakhi A
    Br J Gen Pract; 2007 Apr; 57(537):291-5. PubMed ID: 17394732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: hyperlipidaemia and cardiovascular risk.
    Bertolotti M; Maurantonio M; Gabbi C; Anzivino C; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():28-30. PubMed ID: 16225468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Audiometric pattern as a predictor of cardiovascular status: development of a model for assessment of risk.
    Friedland DR; Cederberg C; Tarima S
    Laryngoscope; 2009 Mar; 119(3):473-86. PubMed ID: 19235737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register.
    Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM
    Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994.
    Rafiei M; Boshtam M; Sarraf-Zadegan N
    East Mediterr Health J; 1999 Jul; 5(4):766-77. PubMed ID: 11338699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Negative aspects of the Western life style and possibilities of intervention in patients with familial combined hyperlipidemia].
    Králíková E; Ceska R; Rames J; Sobra J
    Cas Lek Cesk; 1999 Apr; 138(8):239-44. PubMed ID: 10510543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.
    Mikhailidis DP; Ganotakis ES; Spyropoulos KA; Jagroop IA; Byrne DJ; Winder AF
    Int Angiol; 1998 Dec; 17(4):225-33. PubMed ID: 10204653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.
    Magnani B; Dal Palù C; Zanchetti A;
    Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of reversible cardiovascular risk factors in Israelis aged 25-55 years.
    Tekes-Manova D; Israeli E; Shochat T; Swartzon M; Gordon S; Heruti R; Ashkenazi I; Justo D
    Isr Med Assoc J; 2006 Aug; 8(8):527-31. PubMed ID: 16958240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The screening for asymptomatic vascular disease and risk factors in high risk patients: current practice].
    Simons PC; van der Graaf Y; Banga JD; Eikelboom BC; Algra A
    Ned Tijdschr Geneeskd; 1998 May; 142(19):1096-9. PubMed ID: 9623227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.